COVID-19住院期间谵妄与出院后6个月功能残疾及认知障碍的关联
这项前瞻性队列研究纳入2020年6月18日至2021年6月30日在美国一个大型三级医疗系统5家医院住院的311例60岁及以上COVID-19幸存者,随访至2022年1月11日。住院期间谵妄用CHART-DEL和CHART-DEL-ICU评估,主要结局为出院后1、3、6个月15项功能活动的残疾和认知障碍(蒙特利尔认知评估评分<22)。功能残疾样本311例中49例(15.8%)发生住院谵妄,认知样本271例中31例(11.4%)发生住院谵妄;住院谵妄与出院后6个月内功能残疾增加(率比1.32;95%CI 1.05-1.66)和认知障碍增加(比值比2.48;95%CI 1.38-4.82)相关。作者认为,COVID-19住院的老年幸存者若发生住院谵妄,应在出院随访期间评估残疾和认知障碍。
要点
- COVID-19住院的60岁及以上幸存者中,住院谵妄与出院后6个月内功能残疾增加相关(率比1.32;95%CI 1.05-1.66)。
- 同一人群中,住院谵妄与出院后6个月内认知障碍增加相关(比值比2.48;95%CI 1.38-4.82)。
- 功能残疾样本311例中49例(15.8%)发生住院谵妄;认知样本271例中31例(11.4%)发生住院谵妄。
- 作者建议,COVID-19住院的老年幸存者若发生住院谵妄,应在出院随访期间评估残疾和认知障碍。
适用人群与场景
- 2020年6月18日至2021年6月30日在美国一个大型三级医疗系统5家医院住院的60岁及以上COVID-19幸存者,随访至2022年1月11日。
诊断标准与关键阈值
- 认知障碍定义为蒙特利尔认知评估评分<22。
- 住院期间谵妄使用CHART-DEL和CHART-DEL-ICU评估。
研究设计与关键结果
- 前瞻性队列研究,纳入311例60岁及以上COVID-19住院幸存者(平均[SD]年龄71.3[8.5]岁;女性163例[52.4%]),在美国一个大型三级医疗系统5家医院开展。
- 功能残疾样本311例中49例(15.8%)发生住院谵妄;认知样本271例中31例(11.4%)发生住院谵妄。
- 主要结局为出院后1、3、6个月15项功能活动的残疾和认知障碍(蒙特利尔认知评估评分<22),采用零膨胀负二项和logistic回归模型,调整年龄、随访月份和各自结局的基线(COVID-19前)测量值。
- 住院谵妄与出院后6个月内功能残疾增加相关(率比1.32;95%CI 1.05-1.66)。
- 住院谵妄与出院后6个月内认知障碍增加相关(比值比2.48;95%CI 1.38-4.82)。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,COVID-19住院的老年幸存者若发生住院谵妄,应在出院随访期间评估残疾和认知障碍。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Older adults who are hospitalized for COVID-19 are at risk of delirium. Little is known about the association of in-hospital delirium with functional and cognitive outcomes among older adults who have survived a COVID-19 hospitalization.
OBJECTIVE: To evaluate the association of delirium with functional disability and cognitive impairment over the 6 months after discharge among older adults hospitalized with COVID-19.
DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study involved patients aged 60 years or older who were hospitalized with COVID-19 between June 18, 2020, and June 30, 2021, at 5 hospitals in a major tertiary care system in the US. Follow-up occurred through January 11, 2022. Data analysis was performed from December 2022 to February 2024.
EXPOSURE: Delirium during the COVID-19 hospitalization was assessed using the Chart-based Delirium Identification Instrument (CHART-DEL) and CHART-DEL-ICU.
MAIN OUTCOMES AND MEASURES: Primary outcomes were disability in 15 functional activities and the presence of cognitive impairment (defined as Montreal Cognitive Assessment score <22) at 1, 3, and 6 months after hospital discharge. The associations of in-hospital delirium with functional disability and cognitive impairment were evaluated using zero-inflated negative binominal and logistic regression models, respectively, with adjustment for age, month of follow-up, and baseline (before COVID-19) measures of the respective outcome.
RESULTS: The cohort included 311 older adults (mean [SD] age, 71.3 [8.5] years; 163 female [52.4%]) who survived COVID-19 hospitalization. In the functional disability sample of 311 participants, 49 participants (15.8%) experienced in-hospital delirium. In the cognition sample of 271 participants, 31 (11.4%) experienced in-hospital delirium. In-hospital delirium was associated with both increased functional disability (rate ratio, 1.32; 95% CI, 1.05-1.66) and increased cognitive impairment (odds ratio, 2.48; 95% CI, 1.38-4.82) over the 6 months after discharge from the COVID-19 hospitalization.
CONCLUSIONS AND RELEVANCE: In this cohort study of 311 hospitalized older adults with COVID-19, in-hospital delirium was associated with increased functional disability and cognitive impairment over the 6 months following discharge. Older survivors of a COVID-19 hospitalization who experience in-hospital delirium should be assessed for disability and cognitive impairment during postdischarge follow-up.
参考来源
- Kaushik R, McAvay GJ, Murphy TE, et al. In-Hospital Delirium and Disability and Cognitive Impairment After COVID-19 Hospitalization. JAMA Netw Open. 2024. PMID: 38954414. doi:10.1001/jamanetworkopen.2024.19640
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。